MannKind Stock (NASDAQ: MNKD) stock price, news, charts, stock research, profile.
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Arcutis Biotherapeutics (NASDAQ:ARQT), Xencor (NASDAQ:XNCR), Mesoblast (NASDAQ:MESO) and Agios Pharmaceuticals (NASDAQ:AGIO).
MannKind has a consensus price target of $8.56.
The stock price for MannKind (NASDAQ: MNKD) is $6.85 last updated December 20, 2024 at 6:58 PM EST.
There are no upcoming dividends for MannKind.
MannKind’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.